|
RussianPatents.com
|
Phytotranquiliser. RU patent 2452507. |
|
|
FIELD: medicine, pharmaceutics. SUBSTANCE: invention refers to pharmaceutical industry for the purpose of preparing drugs. The drug contains powdered herbs (valerian, motherwort, melissa, Greek valerian) and/or their dry concentrates and Vitamin C. EFFECT: drug extends the range of tranquilisers for compensation of individual intolerance to certain components of known preparations and provides body recovery from stress consequences, enhances immunity, protects against free radicals accompanying stress. 3 cl, 3 ex
|
|
![Amorphous form of n-{2-fluorine-5-[3-(thiophen-2-carbonyl)-pirazolo[1,5-a]-pyrimidin-7-yl]-phenyl)-n-methyl-acetamide, method for preparing it, pharmaceutical composition (versions) containing said amorphous form and drug and method of treating and/or preventing nervous disorders](http://img.russianpatents.com/img_data/967/9674678-s.gif) Amorphous form of n-{2-fluorine-5-[3-(thiophen-2-carbonyl)-pirazolo[1,5-a]-pyrimidin-7-yl]-phenyl)-n-methyl-acetamide, method for preparing it, pharmaceutical composition (versions) containing said amorphous form and drug and method of treating and/or preventing nervous disorders / 2450005Invention refers to an amorphous form of N-{2- fluorine-5-[3-(thiophen-2-carbonyl)-pyrazolo[1,5-a]-pyrimidin-7-yl]-phenyl}-N-methyl-acetamide, methods for preparing it. |
 Pharmaceutical compositions for depression and anxiety disorder (versions) / 2449804Invention refers to pharmaceutical industry, particularly a pharmaceutical composition for depression and anxiety disorder (versions). Pharmaceutical composition for at least one of depression and anxiety disorder containing ginsenoside Rg1 and Rb1; a glycyrrhizic acid derivative being an acid specified in a group consisting of glycyrrhizic acid, glycyrrhetinic acid and combinations thereof; and cyclic adenosine monophosphate of jojoba (cAMP of jojoba), taken in certain amount. The pharmaceutical composition for treating at least one of depression and anxiety disorder containing ginsenoside Rg1 and Rb1; and a glycyrrhizic acid derivative being specified in a group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination taken in specific proportions. |
 Tranquilliser and functional foodstuff / 2446793There are offered an anxiolytic and/or antidepressant drug which contains vitamin K2 in the amount of 10 mcg to 100 mcg as an active component, a food additive for the same application and an appropriate method of treating. |
 Pharmaceutical composition for treating anxiety / 2444369Invention refers to pharmaceutical industry, particularly to a composition for treating anxiety disorder. The pharmaceutical composition for treating anxiety disorder containing ginsenoside having Rg1 and Rb1; and a glycyrrhizic acid derivative being specified in a group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination taken in specific proportions. The pharmaceutical composition for treating anxiety disorder containing ginseng and liquorice taken in certain proportions. |
|
Method of individual psychologic rehabilitation of patients with prosthetic heart valves / 2444288 Invention relates to medicine, cardiology and cardiac surgery, and can be used for psychological rehabilitation of patients with prosthetic heart valves (PHV). Method includes studying index of development of anxious disorders in pre-operational and post-operational periods and carrying out procedures for patients who have undergone cardiosurgical operations, including drug therapy. In determination of anxiety higher level is considered to be from 31 points and higher, additionally performed are point massage and muscular relaxation successively with groups of muscles of arms, forearms, face, neck, shoulder girdle, abdomen, hips, ankles and feet. Relaxation with each group of muscles is performed for 5-10 seconds 2-3 times per week. |
|
Composition for injections based on crystalline β-modification of 7-brom-1,3-dihydro-5-(2-chlorphenyl)-2h-1,4-benzodiazepin-2-one exhibiting tranquilising action and method for preparing it / 2440120 Group of inventions relates to medicine, in particular to pharmacy. A composition for injections exhibiting tranquilising action contains the ingredients in the following proportions, wt %: crystalline β-modification of 7-brom-1,3-dihydro-5-(2-chlorphenyl)-2H-1,4-benzodiazepin-2-one - 0.05-0.15, polyvinylpyrrolidone - 0.50-1.20, "Tween-80" - 2.00-10.00, glycerine - 5.00-15.00, sodium pyrosulphite - 0.30-1.20, sodium hydrate solution - to pH 6.0-7.5, water - the rest. A method for preparing the composition consist in the fact that "Tween-80" and glycerine are mixed, heated to 70-90°C, and crystalline β-modification of 7-brom-1,3-dihydro-5-(2-chlorphenyl)-2H-1,4-benzodiazepin-2-one is dissolved. The prepared mixture is poured in the mixed aqueous solution of sodium pyrosulphite and polyvinylpyrrolidone heated to 40-90°C, cooled to room temperature, filtered, reduced to pH 6.0-7.5 with sodium hydrate solution, bottled and sterilised. |
 Mglur5 modulators / 2439068Described are novel compounds of general formula I: |
 Agent showing serotonin 5-ht3-receptor antagonist properties / 2438669What is offered is a biologically active substance showing 5-HT3-serotonin receptor antagonist properties, 1-piperidinopropyl-2-(4-fluorophenyl)imidazo[1,2-a]benzimidazole of formula I. The compound has been known as a local anaesthetic. There are shown evident 5-HT3-antagonist properties of the compound in the macromolar concentration equal to the reference preparation ondansetron with the compound of formula I being safer. |
 Medication possessing antidepressive, anxiolytic and nootropic action / 2437659Invention relates to pharmaceutical industry and medicine. Claimed is application of N-carbamoyl-4-(n-methoxyphenyl)-2-pyrrolidone of structural formula as means possessing antidepressive, anxiolytic and nootropic action. This low-toxic compound (LD50 2263.88 mg/kg) possesses high antidepressive, anxiolytic and nootropic activity, affect of which is not accompanied by hypnosedative phenomena, or reduction of mental and physical work ability. |
 Thiophenyl and pyrrolyl azepines as serotonin 5ht2c receptor ligands and use thereof / 2434872Invention relates to compounds of formula , where X denotes S; R1 and R2 taken together with atoms to which they are bonded form a 5-member carbocycle, substituted with up to two substitutes selected from alkyl and CF3; R3 is selected from a group consisting of a hydrogen atom and C1-8-alkyl; R3a denotes a hydrogen atom; R4 denotes a hydrogen atom; R4a denotes a hydrogen atom; R5 denotes a hydrogen atom; R5a denotes a hydrogen atom; R6 denotes a hydrogen atom; R6a denotes a hydrogen atom; R7 denotes a hydrogen atom; or pharmaceutically acceptable salts thereof. The invention also relates to compounds of the given formula, compounds selected from the group, as well as a pharmaceutical composition. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
 Pharmaceutical compositions with multipurpose receptor reaction mechanism for treating depression / 2452505Invention refers to a pharmaceutical composition, particularly to a composition (versions) for treating depression. A pharmaceutical composition with a multipurpose post-receptor mechanism for treating depression containing ginsenosides Rg1 and Rb1; and a glycyrrhizic acid derivative being specified in a group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination taken in specific proportions. The multipurpose post-receptor pharmaceutical composition for treating depression containing ginsenosides Rg1 and Rb1; and the glycyrrhizic acid derivative being specified in the group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination; and a cyclic adenosine monophosphate jojoba (cAMP jojoba) taken in specific proportions. |
|
Pharmaceutical compositions with multipurpose receptor reaction mechanism for treating depression / 2452505 Invention refers to a pharmaceutical composition, particularly to a composition (versions) for treating depression. A pharmaceutical composition with a multipurpose post-receptor mechanism for treating depression containing ginsenosides Rg1 and Rb1; and a glycyrrhizic acid derivative being specified in a group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination taken in specific proportions. The multipurpose post-receptor pharmaceutical composition for treating depression containing ginsenosides Rg1 and Rb1; and the glycyrrhizic acid derivative being specified in the group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination; and a cyclic adenosine monophosphate jojoba (cAMP jojoba) taken in specific proportions. |
|
Pharmaceutical compositions with multipurpose receptor reaction mechanism for treating depression / 2452505 Invention refers to a pharmaceutical composition, particularly to a composition (versions) for treating depression. A pharmaceutical composition with a multipurpose post-receptor mechanism for treating depression containing ginsenosides Rg1 and Rb1; and a glycyrrhizic acid derivative being specified in a group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination taken in specific proportions. The multipurpose post-receptor pharmaceutical composition for treating depression containing ginsenosides Rg1 and Rb1; and the glycyrrhizic acid derivative being specified in the group consisting of glycyrrhizic acid, glycyrrhetinic acid and their combination; and a cyclic adenosine monophosphate jojoba (cAMP jojoba) taken in specific proportions. |
|
Method of treating and preventing metabolic disorders and related pathological conditions and products used therein / 2452504 Group of inventions refers to medicine, namely gastroenterology and nutritional science, and may be used for treating and preventing metabolic and digestive disorders and related pathological conditions. That is ensured by introducing a food combination which contains mechanically processed grain shorts and meat or a dried product specified in the following group: fruit, vegetables, berries or any their combination. |
|
Antibacterial agent / 2452506 Invention refers to chemical-pharmaceutical industry, namely creating a herbal agent showing antibacterial action. The herbal antibacterial agent contains powdered pear fruits in amount 0.1 g to 20.0 g and dry grinded raw plants or dry plant extract in amount 0.1 g to 2.0 g specified in a group: wild camomile, roots of common licorice, blossom of small-leaved lime, leaves of red raspberry, leaves and blossom of sow-foot, herb and blossom of common thyme, root of sweatweed, leaves of garden sage. The antibacterial agent may be presented in the form of a powder, capsules, tablets, granules, sachets, and lozenges. The antibacterial agent is non-toxic and shows additional therapeutic properties: antispasmodic, antipyretic, antitussive, disintoxication and antiallergic. |
| © 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English. |